Evidence map›Paper›PMID 31934218›Full record

ArticleInternational journal of clinical and experimental pathology2019

Primary hepatic follicular lymphoma: a case report and literature review.

Jianjun Xu, Shaobo Hu, Suzhen Li, Yang Gao, Weimin Wang, Xing Zhou, Xiang Cheng, Qichang Zheng

Open access · greenAbstract readCase Reports
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jianjun XuDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Shaobo HuDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Suzhen LiDepartment of Gastroenterology, Wuhan Asia General Hospital Wuhan, China.
Yang GaoDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Weimin WangDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Xing ZhouDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Xiang ChengDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Qichang ZhengDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Wuhan Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtranodal lymphomas commonly occur in the spleen, but the likelihood of primary liver lymphomas is low. As such, studies on the diagnosis and treatment of primary hepatic follicular lymphoma are limited. CASE PRESENTATION: Two liver space-occupying lesions were found in a 53-year-old female patient through magnetic resonance imaging (MRI). This patient was preoperatively diagnosed with a malignant tumor of the liver without a liver biopsy. The patient underwent a hepatectomy, a cholecystectomy, and microwave ablation. A definitive diagnosis of follicular lymphoma was confirmed by the pathological examination. Postoperative rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) were administered. The patient survived without a recurrence of the tumor during the two years of follow-up.

conclusionsPrimary hepatic follicular lymphoma is a rare malignant tumor of the liver. Surgical resection of the lesions followed by adjuvant chemotherapy might prevent recurrence in cases of hepatic follicular lymphoma.

Indexed as

chemotherapyfollicular lymphomaoperationPrimary hepatic lymphoma

Identifiers

PMID31934218
PMCPMC6949803
OpenAlexW3008280720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.